Ncardia's Remarkable Journey in 2023: A Year of Growth, Innovation, and Leadership

Published on February 15, 2024
Ncardia's Remarkable Journey in 2023: A Year of Growth, Innovation, and Leadership

As we step into the new year, Ncardia is delighted to reflect on the transformative journey of 2023, marked by innovation, expansion, and strategic leadership. Throughout the year, we launched several initiatives aimed at advancing the use of induced pluripotent stem cells (iPSCs) to revolutionize drug discovery. Here are some key highlights that defined our remarkable year:

Continue reading on website
Other news

Southeastern Pennsylvania is getting its first micro-hospitals

February 13, 2024
Source: The Philadelphia InquirerThe 10-bed hospitals with small emergency departments in Chester County and Montgomery County will help ChristianaCare and Lehigh Valley Health Network expand their markets.Southeastern Pennsylvania will get its first micro-hospitals – facilities with small emergency departments and 10 inpatient beds for people who are not seriously ill – as ChristianaCare and Lehi

Blog: 10 Things to Consider When Developing an ADC

February 16, 2024
What to be aware of when navigating the complexities of ADC innovationAntibody-drug conjugates (ADCs) have emerged as a groundbreaking advancement in oncology, promising improved patient outcomes and quality of life. However, developing these complex therapeutics involves numerous challenges and considerations. As we venture further into this field, it is essential to consider the many challenges